BIOCANCELL THERAPEUTICS INC. Stock-Based Compensation
BIOCANCELL THERAPEUTICS INC. reported Stock-Based Compensation of $50.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-05-10
- BIOCANCELL THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $50.00K, a 68.94% decline year-over-year.
- BIOCANCELL THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $6.00K, a 94.06% decline year-over-year.
- BIOCANCELL THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2011-09-30 was $42.00K, a 46.84% decline year-over-year.
- BIOCANCELL THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2011-06-30 was $101.00K.
- BIOCANCELL THERAPEUTICS INC. share-based payment arrangement, noncash expense for fiscal 2011 was $310.00K, a 21.52% decline from fiscal 2010.
- BIOCANCELL THERAPEUTICS INC. share-based payment arrangement, noncash expense for fiscal 2010 was $395.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 81 month | Share-based Payment Arrangement, Noncash Expense 84 month | Share-based Payment Arrangement, Noncash Expense 87 month | Share-based Payment Arrangement, Noncash Expense 90 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | $50.00K 10-Q · filed 2012-05-10 | $56.00K derived: sum of 2 quarters · filed 2012-05-10 | $98.00K derived: sum of 3 quarters · filed 2012-05-10 | $199.00K derived: sum of 4 quarters · filed 2012-05-10 | $2.40M 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $48.00K derived: sum of 2 quarters · filed 2012-03-30 | $149.00K derived: sum of 3 quarters · filed 2012-03-30 | $310.00K 10-K · filed 2012-03-30 | $2.35M 10-K · filed 2012-03-30 | |||
| 2011-09-30 | $42.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $143.00K derived: sum of 2 quarters · filed 2011-11-07 | $304.00K 10-Q · filed 2011-11-07 | $405.00K derived: sum of 4 quarters · filed 2012-05-10 | $2.34M 10-Q · filed 2011-11-07 | |||
| 2011-06-30 | $101.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-08-30 | $262.00K 10-Q/A · filed 2011-08-30 | $363.00K derived: sum of 3 quarters · filed 2012-05-10 | $442.00K derived: sum of 4 quarters · filed 2012-05-10 | $2.30M 10-Q/A · filed 2011-08-30 | |||
| 2011-03-31 | $161.00K 10-Q · filed 2012-05-10 | $262.00K derived: sum of 2 quarters · filed 2012-05-10 | $341.00K derived: sum of 3 quarters · filed 2012-05-10 | |||||
| 2010-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $180.00K derived: sum of 2 quarters · filed 2012-03-30 | $395.00K 10-K · filed 2012-03-30 | |||||
| 2010-09-30 | $79.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $294.00K 10-Q · filed 2011-11-07 | ||||||
| 2010-06-30 | $215.00K 10-Q/A · filed 2011-08-30 |